Nova krvna pretraga mogla bi pomo\u0107i "personalizaciji" imunoterapije za tumore - Abra\u0161MEDIA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nova krvna pretraga mogla bi pomo\u0107i "personalizaciji" imunoterapije za tumore - Abra\u0161MEDIA\" \/>\n<meta property=\"og:description\" content=\"Prvi podaci Rocheova testa, kojim se odre\u0111uje mutacijsko optere\u0107enje tumora (TMB), objavljeni su na kongresu Europskog dru\u0161tva medicinske onkologije (ESMO) u Madridu. Nova krvna pretraga farmaceutske tvrtke Roche i zaklade Medicine precizno mjeri broj mutacija u tumoru, \u010dime bi se moglo predvidjeti koji pacijenti najbolje…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/\" \/>\n<meta property=\"og:site_name\" content=\"Abra\u0161MEDIA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Abra%c5%a1MEDIA-174912181121\/?fref=ts\" \/>\n<meta property=\"article:published_time\" content=\"2017-09-10T18:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-09-10T16:18:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"660\" \/>\n\t<meta property=\"og:image:height\" content=\"330\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@admin\" \/>\n<meta name=\"twitter:site\" content=\"@abrasmedia\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/abrasmedia.info\/#\/schema\/person\/a975ed87587887d9a7dc5f7d86658507\"},\"headline\":\"Nova krvna pretraga mogla bi pomo\u0107i “personalizaciji” imunoterapije za tumore\",\"datePublished\":\"2017-09-10T18:00:00+00:00\",\"dateModified\":\"2017-09-10T16:18:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/\"},\"wordCount\":222,\"publisher\":{\"@id\":\"https:\/\/abrasmedia.info\/#organization\"},\"image\":{\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg\",\"articleSection\":[\"Nauka\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/\",\"url\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/\",\"name\":\"Nova krvna pretraga mogla bi pomo\u0107i \\\"personalizaciji\\\" imunoterapije za tumore - Abra\u0161MEDIA\",\"isPartOf\":{\"@id\":\"https:\/\/abrasmedia.info\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg\",\"datePublished\":\"2017-09-10T18:00:00+00:00\",\"dateModified\":\"2017-09-10T16:18:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#primaryimage\",\"url\":\"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg\",\"contentUrl\":\"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg\",\"width\":660,\"height\":330,\"caption\":\"Ilustracija\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/abrasmedia.info\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nova krvna pretraga mogla bi pomo\u0107i “personalizaciji” imunoterapije za tumore\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/abrasmedia.info\/#website\",\"url\":\"https:\/\/abrasmedia.info\/\",\"name\":\"Abra\u0161MEDIA\",\"description\":\"Dru\u0161tveno anga\u017eirani medij\",\"publisher\":{\"@id\":\"https:\/\/abrasmedia.info\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/abrasmedia.info\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/abrasmedia.info\/#organization\",\"name\":\"Abra\u0161MEDIA\",\"url\":\"https:\/\/abrasmedia.info\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/abrasmedia.info\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/abrasmedia.info\/wp-content\/uploads\/2016\/12\/abrasmedia_logo2-2.png\",\"contentUrl\":\"http:\/\/abrasmedia.info\/wp-content\/uploads\/2016\/12\/abrasmedia_logo2-2.png\",\"width\":512,\"height\":110,\"caption\":\"Abra\u0161MEDIA\"},\"image\":{\"@id\":\"https:\/\/abrasmedia.info\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Abra\u0161MEDIA-174912181121\/?fref=ts\",\"https:\/\/x.com\/abrasmedia\",\"https:\/\/www.youtube.com\/user\/abrasmedia\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/abrasmedia.info\/#\/schema\/person\/a975ed87587887d9a7dc5f7d86658507\",\"name\":\"admin\",\"sameAs\":[\"https:\/\/x.com\/admin\"],\"url\":\"https:\/\/abrasmedia.info\/author\/admin\/\"}]}<\/script>\n","yoast_head_json":{"title":"Nova krvna pretraga mogla bi pomo\u0107i \"personalizaciji\" imunoterapije za tumore - Abra\u0161MEDIA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/","og_locale":"en_US","og_type":"article","og_title":"Nova krvna pretraga mogla bi pomo\u0107i \"personalizaciji\" imunoterapije za tumore - Abra\u0161MEDIA","og_description":"Prvi podaci Rocheova testa, kojim se odre\u0111uje mutacijsko optere\u0107enje tumora (TMB), objavljeni su na kongresu Europskog dru\u0161tva medicinske onkologije (ESMO) u Madridu. Nova krvna pretraga farmaceutske tvrtke Roche i zaklade Medicine precizno mjeri broj mutacija u tumoru, \u010dime bi se moglo predvidjeti koji pacijenti najbolje…","og_url":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/","og_site_name":"Abra\u0161MEDIA","article_publisher":"https:\/\/www.facebook.com\/Abra%c5%a1MEDIA-174912181121\/?fref=ts","article_published_time":"2017-09-10T18:00:00+00:00","article_modified_time":"2017-09-10T16:18:00+00:00","og_image":[{"width":660,"height":330,"url":"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@admin","twitter_site":"@abrasmedia","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#article","isPartOf":{"@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/"},"author":{"name":"admin","@id":"https:\/\/abrasmedia.info\/#\/schema\/person\/a975ed87587887d9a7dc5f7d86658507"},"headline":"Nova krvna pretraga mogla bi pomo\u0107i “personalizaciji” imunoterapije za tumore","datePublished":"2017-09-10T18:00:00+00:00","dateModified":"2017-09-10T16:18:00+00:00","mainEntityOfPage":{"@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/"},"wordCount":222,"publisher":{"@id":"https:\/\/abrasmedia.info\/#organization"},"image":{"@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#primaryimage"},"thumbnailUrl":"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg","articleSection":["Nauka"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/","url":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/","name":"Nova krvna pretraga mogla bi pomo\u0107i \"personalizaciji\" imunoterapije za tumore - Abra\u0161MEDIA","isPartOf":{"@id":"https:\/\/abrasmedia.info\/#website"},"primaryImageOfPage":{"@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#primaryimage"},"image":{"@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#primaryimage"},"thumbnailUrl":"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg","datePublished":"2017-09-10T18:00:00+00:00","dateModified":"2017-09-10T16:18:00+00:00","breadcrumb":{"@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#primaryimage","url":"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg","contentUrl":"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg","width":660,"height":330,"caption":"Ilustracija"},{"@type":"BreadcrumbList","@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/abrasmedia.info\/"},{"@type":"ListItem","position":2,"name":"Nova krvna pretraga mogla bi pomo\u0107i “personalizaciji” imunoterapije za tumore"}]},{"@type":"WebSite","@id":"https:\/\/abrasmedia.info\/#website","url":"https:\/\/abrasmedia.info\/","name":"Abra\u0161MEDIA","description":"Dru\u0161tveno anga\u017eirani medij","publisher":{"@id":"https:\/\/abrasmedia.info\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/abrasmedia.info\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/abrasmedia.info\/#organization","name":"Abra\u0161MEDIA","url":"https:\/\/abrasmedia.info\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/abrasmedia.info\/#\/schema\/logo\/image\/","url":"http:\/\/abrasmedia.info\/wp-content\/uploads\/2016\/12\/abrasmedia_logo2-2.png","contentUrl":"http:\/\/abrasmedia.info\/wp-content\/uploads\/2016\/12\/abrasmedia_logo2-2.png","width":512,"height":110,"caption":"Abra\u0161MEDIA"},"image":{"@id":"https:\/\/abrasmedia.info\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Abra\u0161MEDIA-174912181121\/?fref=ts","https:\/\/x.com\/abrasmedia","https:\/\/www.youtube.com\/user\/abrasmedia"]},{"@type":"Person","@id":"https:\/\/abrasmedia.info\/#\/schema\/person\/a975ed87587887d9a7dc5f7d86658507","name":"admin","sameAs":["https:\/\/x.com\/admin"],"url":"https:\/\/abrasmedia.info\/author\/admin\/"}]}},"jetpack_featured_media_url":"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/posts\/11804"}],"collection":[{"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/comments?post=11804"}],"version-history":[{"count":1,"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/posts\/11804\/revisions"}],"predecessor-version":[{"id":11806,"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/posts\/11804\/revisions\/11806"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/media\/11805"}],"wp:attachment":[{"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/media?parent=11804"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/categories?post=11804"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/tags?post=11804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

Deprecated: Function jetpack_form_register_pattern is deprecated since version jetpack-13.4! Use Automattic\Jetpack\Forms\ContactForm\Util::register_pattern instead. in /home2/abras/public_html/wp-includes/functions.php on line 6078

Warning: Cannot modify header information - headers already sent by (output started at /home2/abras/public_html/wp-includes/functions.php:6078) in /home2/abras/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home2/abras/public_html/wp-includes/functions.php:6078) in /home2/abras/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home2/abras/public_html/wp-includes/functions.php:6078) in /home2/abras/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home2/abras/public_html/wp-includes/functions.php:6078) in /home2/abras/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home2/abras/public_html/wp-includes/functions.php:6078) in /home2/abras/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home2/abras/public_html/wp-includes/functions.php:6078) in /home2/abras/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home2/abras/public_html/wp-includes/functions.php:6078) in /home2/abras/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home2/abras/public_html/wp-includes/functions.php:6078) in /home2/abras/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1831
{"id":11804,"date":"2017-09-10T20:00:00","date_gmt":"2017-09-10T18:00:00","guid":{"rendered":"http:\/\/abrasmedia.info\/?p=11804"},"modified":"2017-09-10T18:18:00","modified_gmt":"2017-09-10T16:18:00","slug":"nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore","status":"publish","type":"post","link":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/","title":{"rendered":"Nova krvna pretraga mogla bi pomo\u0107i “personalizaciji” imunoterapije za tumore"},"content":{"rendered":"

Prvi podaci Rocheova testa, kojim se odre\u0111uje mutacijsko optere\u0107enje tumora (TMB), objavljeni su na kongresu Europskog dru\u0161tva medicinske onkologije (ESMO) u Madridu.<\/p>\n

Nova krvna pretraga farmaceutske tvrtke Roche i zaklade Medicine precizno mjeri broj mutacija u tumoru, \u010dime bi se moglo predvidjeti koji pacijenti najbolje reagiraju na odre\u0111ene vrste imunoterapije.<\/p>\n

Postoje\u0107e imunoterapije daju odre\u0111enu nadu pacijentima oboljelima od smrtonosnih tumora, ali djeluju samo kod nekih od njih.<\/p>\n

Bolje reakcije na imunoterapiju<\/strong><\/p>\n

Osim toga, uzimaju\u0107i u obzir visoku cijenu i mogu\u0107e \u0161tetne nuspojave, lije\u010dnici bi \u017eeljeli imati pouzdaniji na\u010din kojim bi odredili pacijente s o\u010dekivanim najboljim u\u010dinkom takve vrste lije\u010denja.<\/p>\n

Istra\u017eivanje je pokazalo da tumori s vi\u0161e mutacija bolje reagiraju na imunoterapiju, ka\u017eu u Rocheu, dodaju\u0107i kako se nadaju da \u0107e njihov test pobolj\u0161ati mjerenje TMB-a, posebno kada invazivne biopsije nisu izvedive. Takav krvni test u ovome trenutku ne postoji na tr\u017ei\u0161tu, prenosi Hina.<\/p>\n

“Biomarkeri ne\u0107e nam pomo\u0107i samo u boljem razumijevanju imunobiologije, nego \u0107e nam pomo\u0107i da terapije prilagodimo ljudima koji bi od njih trebali imati najvi\u0161e koristi”, rekla je Sandra Horning, medicinska direktorica \u0161vicarske farmaceutske kompanije.<\/p>\n

Roche trenutno razvija 20 imunoterapijskih lijekova za devet vrsta tumora.<\/p>\n

(HINA)<\/p>\n","protected":false},"excerpt":{"rendered":"

Prvi podaci Rocheova testa, kojim se odre\u0111uje mutacijsko optere\u0107enje tumora (TMB), objavljeni su na kongresu Europskog dru\u0161tva medicinske onkologije (ESMO) u Madridu. Nova krvna pretraga farmaceutske tvrtke Roche i zaklade Medicine precizno mjeri broj mutacija u tumoru, \u010dime bi se moglo predvidjeti koji pacijenti najbolje… <\/p>\n","protected":false},"author":1,"featured_media":11805,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_FSMCFIC_featured_image_caption":"","_FSMCFIC_featured_image_nocaption":"","_FSMCFIC_featured_image_hide":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[16],"tags":[],"yoast_head":"\nNova krvna pretraga mogla bi pomo\u0107i "personalizaciji" imunoterapije za tumore - Abra\u0161MEDIA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nova krvna pretraga mogla bi pomo\u0107i "personalizaciji" imunoterapije za tumore - Abra\u0161MEDIA\" \/>\n<meta property=\"og:description\" content=\"Prvi podaci Rocheova testa, kojim se odre\u0111uje mutacijsko optere\u0107enje tumora (TMB), objavljeni su na kongresu Europskog dru\u0161tva medicinske onkologije (ESMO) u Madridu. Nova krvna pretraga farmaceutske tvrtke Roche i zaklade Medicine precizno mjeri broj mutacija u tumoru, \u010dime bi se moglo predvidjeti koji pacijenti najbolje…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/\" \/>\n<meta property=\"og:site_name\" content=\"Abra\u0161MEDIA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Abra%c5%a1MEDIA-174912181121\/?fref=ts\" \/>\n<meta property=\"article:published_time\" content=\"2017-09-10T18:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-09-10T16:18:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"660\" \/>\n\t<meta property=\"og:image:height\" content=\"330\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@admin\" \/>\n<meta name=\"twitter:site\" content=\"@abrasmedia\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/abrasmedia.info\/#\/schema\/person\/a975ed87587887d9a7dc5f7d86658507\"},\"headline\":\"Nova krvna pretraga mogla bi pomo\u0107i “personalizaciji” imunoterapije za tumore\",\"datePublished\":\"2017-09-10T18:00:00+00:00\",\"dateModified\":\"2017-09-10T16:18:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/\"},\"wordCount\":222,\"publisher\":{\"@id\":\"https:\/\/abrasmedia.info\/#organization\"},\"image\":{\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg\",\"articleSection\":[\"Nauka\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/\",\"url\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/\",\"name\":\"Nova krvna pretraga mogla bi pomo\u0107i \\\"personalizaciji\\\" imunoterapije za tumore - Abra\u0161MEDIA\",\"isPartOf\":{\"@id\":\"https:\/\/abrasmedia.info\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg\",\"datePublished\":\"2017-09-10T18:00:00+00:00\",\"dateModified\":\"2017-09-10T16:18:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#primaryimage\",\"url\":\"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg\",\"contentUrl\":\"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg\",\"width\":660,\"height\":330,\"caption\":\"Ilustracija\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/abrasmedia.info\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nova krvna pretraga mogla bi pomo\u0107i “personalizaciji” imunoterapije za tumore\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/abrasmedia.info\/#website\",\"url\":\"https:\/\/abrasmedia.info\/\",\"name\":\"Abra\u0161MEDIA\",\"description\":\"Dru\u0161tveno anga\u017eirani medij\",\"publisher\":{\"@id\":\"https:\/\/abrasmedia.info\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/abrasmedia.info\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/abrasmedia.info\/#organization\",\"name\":\"Abra\u0161MEDIA\",\"url\":\"https:\/\/abrasmedia.info\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/abrasmedia.info\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/abrasmedia.info\/wp-content\/uploads\/2016\/12\/abrasmedia_logo2-2.png\",\"contentUrl\":\"http:\/\/abrasmedia.info\/wp-content\/uploads\/2016\/12\/abrasmedia_logo2-2.png\",\"width\":512,\"height\":110,\"caption\":\"Abra\u0161MEDIA\"},\"image\":{\"@id\":\"https:\/\/abrasmedia.info\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Abra\u0161MEDIA-174912181121\/?fref=ts\",\"https:\/\/x.com\/abrasmedia\",\"https:\/\/www.youtube.com\/user\/abrasmedia\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/abrasmedia.info\/#\/schema\/person\/a975ed87587887d9a7dc5f7d86658507\",\"name\":\"admin\",\"sameAs\":[\"https:\/\/x.com\/admin\"],\"url\":\"https:\/\/abrasmedia.info\/author\/admin\/\"}]}<\/script>\n","yoast_head_json":{"title":"Nova krvna pretraga mogla bi pomo\u0107i \"personalizaciji\" imunoterapije za tumore - Abra\u0161MEDIA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/","og_locale":"en_US","og_type":"article","og_title":"Nova krvna pretraga mogla bi pomo\u0107i \"personalizaciji\" imunoterapije za tumore - Abra\u0161MEDIA","og_description":"Prvi podaci Rocheova testa, kojim se odre\u0111uje mutacijsko optere\u0107enje tumora (TMB), objavljeni su na kongresu Europskog dru\u0161tva medicinske onkologije (ESMO) u Madridu. Nova krvna pretraga farmaceutske tvrtke Roche i zaklade Medicine precizno mjeri broj mutacija u tumoru, \u010dime bi se moglo predvidjeti koji pacijenti najbolje…","og_url":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/","og_site_name":"Abra\u0161MEDIA","article_publisher":"https:\/\/www.facebook.com\/Abra%c5%a1MEDIA-174912181121\/?fref=ts","article_published_time":"2017-09-10T18:00:00+00:00","article_modified_time":"2017-09-10T16:18:00+00:00","og_image":[{"width":660,"height":330,"url":"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@admin","twitter_site":"@abrasmedia","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#article","isPartOf":{"@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/"},"author":{"name":"admin","@id":"https:\/\/abrasmedia.info\/#\/schema\/person\/a975ed87587887d9a7dc5f7d86658507"},"headline":"Nova krvna pretraga mogla bi pomo\u0107i “personalizaciji” imunoterapije za tumore","datePublished":"2017-09-10T18:00:00+00:00","dateModified":"2017-09-10T16:18:00+00:00","mainEntityOfPage":{"@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/"},"wordCount":222,"publisher":{"@id":"https:\/\/abrasmedia.info\/#organization"},"image":{"@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#primaryimage"},"thumbnailUrl":"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg","articleSection":["Nauka"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/","url":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/","name":"Nova krvna pretraga mogla bi pomo\u0107i \"personalizaciji\" imunoterapije za tumore - Abra\u0161MEDIA","isPartOf":{"@id":"https:\/\/abrasmedia.info\/#website"},"primaryImageOfPage":{"@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#primaryimage"},"image":{"@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#primaryimage"},"thumbnailUrl":"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg","datePublished":"2017-09-10T18:00:00+00:00","dateModified":"2017-09-10T16:18:00+00:00","breadcrumb":{"@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#primaryimage","url":"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg","contentUrl":"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg","width":660,"height":330,"caption":"Ilustracija"},{"@type":"BreadcrumbList","@id":"https:\/\/abrasmedia.info\/nova-krvna-pretraga-mogla-bi-pomoci-personalizaciji-imunoterapije-za-tumore\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/abrasmedia.info\/"},{"@type":"ListItem","position":2,"name":"Nova krvna pretraga mogla bi pomo\u0107i “personalizaciji” imunoterapije za tumore"}]},{"@type":"WebSite","@id":"https:\/\/abrasmedia.info\/#website","url":"https:\/\/abrasmedia.info\/","name":"Abra\u0161MEDIA","description":"Dru\u0161tveno anga\u017eirani medij","publisher":{"@id":"https:\/\/abrasmedia.info\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/abrasmedia.info\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/abrasmedia.info\/#organization","name":"Abra\u0161MEDIA","url":"https:\/\/abrasmedia.info\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/abrasmedia.info\/#\/schema\/logo\/image\/","url":"http:\/\/abrasmedia.info\/wp-content\/uploads\/2016\/12\/abrasmedia_logo2-2.png","contentUrl":"http:\/\/abrasmedia.info\/wp-content\/uploads\/2016\/12\/abrasmedia_logo2-2.png","width":512,"height":110,"caption":"Abra\u0161MEDIA"},"image":{"@id":"https:\/\/abrasmedia.info\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Abra\u0161MEDIA-174912181121\/?fref=ts","https:\/\/x.com\/abrasmedia","https:\/\/www.youtube.com\/user\/abrasmedia"]},{"@type":"Person","@id":"https:\/\/abrasmedia.info\/#\/schema\/person\/a975ed87587887d9a7dc5f7d86658507","name":"admin","sameAs":["https:\/\/x.com\/admin"],"url":"https:\/\/abrasmedia.info\/author\/admin\/"}]}},"jetpack_featured_media_url":"https:\/\/abrasmedia.info\/wp-content\/uploads\/2017\/09\/laboratorija-istrazivanja-tumori-krv.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/posts\/11804"}],"collection":[{"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/comments?post=11804"}],"version-history":[{"count":1,"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/posts\/11804\/revisions"}],"predecessor-version":[{"id":11806,"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/posts\/11804\/revisions\/11806"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/media\/11805"}],"wp:attachment":[{"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/media?parent=11804"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/categories?post=11804"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/abrasmedia.info\/wp-json\/wp\/v2\/tags?post=11804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}